33results about How to "Active treatment" patented technology

The invention discloses a portable brain function biofeedback instrument, comprising a calculation analysis module, a human-computer interaction module, a storage module and a control module which are sequentially connected with each other. The calculation analysis module consists of an electroencephalophone measurement lead of an input sensor connecting with a human body, an amplifying and frequency-selecting module, a lead drop-off automatic detection module, a screen drive and right leg drive module, an A/D sampling and converting module and a DSP; the human-computer interaction module consists of a touch screen and a speaker; the storage module consists of an standard deviation (SD) card; and the control module consists of an embedded ARM micro-processor. The calculation analysis module realizes extraction of alpha wave, beta wave and theta wave of a characteristic electroencephalophone component to give an electroencephalophone active mode; and the storage module realizes storage of data and an analysis result. The portable brain function biofeedback instrument feeds back the electroencephalophone information to a trainee through detecting the electroencephalophone information by an engineering technology, and generates the lasting effect through a repeated training to enable the brain to develop towards a normal and healthy level. An electroencephalophone biofeedback therapy can further and fully mobilize the internal potential of the trainee so that the trainee actively participates in the treatment.

The present invention relates to a special clinical nutritional formula for anemia. The nutritional formula comprises proteins, fats, carbohydrates, dietary fibers, macro elements, trace elements, vitamins, dietary essences, medicinal and edible ingredients, natural plant compounds and new resource food. The dietary essences comprise beef powder, pork liver powder, red date powder and cherry powder. The medicinal and edible ingredients comprise Chinese yams, Chinese wolfberry fruits, chicken's gizzard-membrane, haws, cloves, orange peels and honeysuckles. A preparation method comprises the following steps: each component is prepared into powder in advance, then the corresponding dosage forms are prepared, wherein the medicinal and edible ingredients are subjected to water extracting, concentrating is performed, the concentrated ingredients are spray-dried to prepare powder, and the vitamins and fats are subjected to microencapsulation treatment to prepare powder; or a wet method technology is used to conduct emulsifying and homogenizing on the ingredients, and the homogenized ingredients are spray-dried to prepare powder. Compared with the prior art, the nutritional formula can provide energy, key nutrients and essential trace elements for patients with anemia, and improves and treats anemia syndromes caused by insufficient nutrient intake and iron deficiency.

The invention relates to a special clinical nutrient composition for an inflammatory bowel disease. The special clinical nutrient composition comprises protein, amino acid, peptides, fat, carbohydrate, dietary fibers, macro-elements, micro-elements, vitamins, dietary essence, medicinal and edible components, natural plant compounds and new resource food, wherein the dietary essence comprises millet powder, oat powder and apple powder, and the medicinal and edible components comprise lanceleaf lily bulbs, wild mint herbs, ural licorice roots, Indian bread, palmleaf raspberry fruits, barbary wolfberry fruits, king solomonseal rhizome and Chinese dates. A preparation method of the special clinical nutrient composition includes the steps: preparing the components into powder in advance and uniformly mixing the powder to prepare corresponding forms; performing water extracting concentration and freeze drying on the medicinal and edible components to prepare powder, microencapsulating the vitamins and the fat into powder and freeze-drying the dietary essence into powder. Compared with the prior art, the nutrient composition can provide needed energy, key nutrients and necessary micro-elements for a patient suffering from the inflammatory bowel disease, and improve blood sedimentation, C reactive protein and intestinal mucosa permeability symptoms of the patient.

The invention discloses a coma patient analepsia prediction method. The method comprises the steps of 1, stimulation arrangement, 2, event related potential (ERP) detection, 3, waveform treatment, and 4, waveform recognition. According to the method, stimulation schemes including TON-MMN and SON-P300 are integrated, by means of the ERP technique, the consciousness recovery condition of a patient suffering from coma caused by cerebral injury, anoxia and metabolism can be monitored in real time, and the probability of analepsia of the coma patient is predicted comprehensively by means of indexes including N100, MMN and P3a, so that the coma patient has confidence in continuous and positive treatment. Compared with other nerve electrophysiology examination (BAEP, SEP) methods, the method has the advantage of being high in prediction sensitivity, high in specificity and high in prediction accuracy.

The invention relates to a clinical nutrition formula special for female sterility. The clinical nutrition formula contains proteins, amino acid, fat, carbohydrate, dietary fiber, macroelements, microelements, vitamins, dietary essences, medical-edible components, natural plant compounds and new resource food, wherein the dietary essences include black bean powder; the medical-edible components are selected from at least one of mint, poria, liquorice, rhizoma polygonati, chrysanthemum, dandelion, Chinese yam, Chinese dates, Houttuynia cordata, platycodon grandiflorum, honeysuckles and radix puerariae. The preparation method comprises the steps of grinding the components into powder, and preparing corresponding dose forms, wherein the medical-edible components are prepared into powder through water extraction, concentration and spray drying, and the vitamins and the fat are prepared into powder through microencapsulation. Compared with the prior art, the clinical nutrition formula is capable of providing comprehensive nutrition support to patients with female sterility, so that the malnutrition state is improved; meanwhile, by adding the medical-edible components having the efficacies of nourishing kidney, tonifying spleen and soothing liver, the pregnancy of the patients can be promoted.

The invention discloses epileptic seizure recording and management patient equipment, a server, medical equipment, and a system. The patient equipment comprises a patient input module which is used for receiving seizure condition information and pharmacy condition information of an epileptic; a first information transmitting module which is used for enabling the seizure condition information and pharmacy condition information to be transmitted; a first information receiving module which is used for receiving treatment suggestion information generated according to the seizure condition information and pharmacy condition information; and an information display module which is used for displaying the treatment suggestion information. According to the invention, a patient can increase the understanding of the change of the state of an illness, thereby prompting the patient to timely go to an epilepsy department to see a doctor. Meanwhile, the equipment can help a clinic doctor know the evolution process of the illness of the patient quickly during clinical reception, thereby facilitating the reduction of clinical inquiry time and improving the treatment efficiency. In addition, the epileptic seizure data recorded by the system can be used for scientific research. Accordingly, the above technical scheme is of great significance to the patient, clinicists and scientific research personnel.

Disclosed is a gene sensitive to a normal-tension glaucoma disease. Also disclosed is a method for utilizing the gene. Comprehensive analysis/comparison was made on single nucleotide polymorphisms on the entire genome in many normal-tension glaucoma patients and many normal persons, and it is found that there is a difference in polymorphism sites found in ELOVL5-containing regions on human chromosome-6 and the like among the patients and the normal persons, wherein the polymorphism sites are represented by the international single nucleotide polymorphism numbers rs222450, rs9474394, rs2816344, rs2816341, rs2518579, rs2518578, rs9367511, rs6915699, rs6930045, rs9370188, rs9382180, rs9382181, rs4486010, rs2816379, rs6939730, rs2817088, rs2817090, rs2816372, rs2562895, rs2816364, rs2562893, rs2817101, rs2816362, rs2816356, rs10948744, rs12183976, rs2562898, rs735860, rs715441, rs2057024, rs1429146, rs9463895, rs2235723, rs1346603, rs9474476, rs2294867, rs9349660, rs974323, rs6909592, rs9367520, rs9395854, rs209485, rs9395856, rs7747926, rs7738788, rs209500, rs9357760, rs9370196, rs209512, rs209517, rs9370201, rs9367529, rs12209741, rs7744451, rs6904083, rs6904376, rs9367532, rs2067833, rs9382212, rs2139077, rs2397146, rs7742367, rs9474576, rs622447, rs3736729, rs13212365 and rs761141. It becomes possible to diagnose normal-tension glaucoma based on the difference in those polymorphism sites.

Provided are a normal-tension glaucoma susceptibility gene and a method for using the same. Comprehensive analysis and comparison of single-nucleotide polymorphism on the entire genome of a large number of normal-tension glaucoma patients and normal subjects led to the discovery of differences in polymorphism sites, and it was discovered that of these different polymorphism sites, the polymorphism sites of single-nucleotide polymorphism international No. rs3213787, No. rs735860, No. rs4412249, and No. rs2763979 are effective in the diagnosis of normal-tension glaucoma.

The invention discloses an intelligent electronic device with a cardiac rhythm detecting function. The device comprises a toilet seat provided with at least one first cardiac rhythm detecting sensor, the first cardiac rhythm detecting sensor is electrically connected with a cardiac rhythm detecting module, and the collected cardiac rhythm data is transmitted to the cardiac rhythm detecting module; the received cardiac rhythm data is processed and judged by the cardiac rhythm detecting module, and a judgment result is transmitted to an intelligent module of the toilet to display; and/ or the received cardiac rhythm data is uploaded to a cloud server by the cardiac rhythm detecting module, and a diagnosis result is sent to an intelligent terminal of users by the cloud server. The intelligent electronic device with the cardiac rhythm detecting function has the advantages that the usage is simple and convenient, the users can directly use the intelligent electronic device at home to collect the cardiac rhythm data, the device is beneficial for long-term viewing of some diseases, the users do not need to be hospitalized and monitored, the manual labor is saved and the time is saved.

The invention relates to an SNP marker related to prognosis of esophageal cancer patients and application thereof. The marker is rs2274110. According to the invention, by skillful primer and probe design aiming at the rs2274110 locus, the MCM10 variation detection can be carried out on the esophageal cancer patient by means of fluorescence quantitative PCR, so that high-risk individuals among esophageal cancer patient can be identified, and the judgment on the overall prognosis of the esophageal cancer patients can be assisted. The technical method is ingenious in design, simple and feasible,and accurate and reliable in result, can be popularized in hospitals at all levels, is helpful for evaluating the disease prognosis condition of the esophageal cancer, and is helpful for more active treatment and close follow-up visit on patients with poor prognosis of the esophageal cancer clinically.

The invention discloses a big data processing method and device for chronic kidney disease management. The method provided by the invention is simple and reasonable in steps, can analyze and process glomerular filtration rate data, urine protein data, blood pressure data, blood sugar data, blood uric acid data and blood fat data for managing chronic kidney diseases, and can obtain an accurate processing result report. The report can be used as a reference for medical staff to treat a patient, brings convenience to the medical staff, enables the medical staff to carry out work easily, and can urge the patient to actively go to a hospital for treatment to prevent further harm to economy, life and the like of the patient. The device is simple in structure, convenient to carry and convenient to use, the modes of inputting glomerular filtration rate data, urine protein data, blood pressure data, blood sugar data, blood uric acid data and blood fat data are diversified, the modes of transmitting processing result reports are diversified, and the use requirements of patients can be well met.

The invention belongs to the field of traditional Chinese medicine formulations and provides a compound traditional Chinese medicine formulation with dandelion herb for use in cancer discovery stage,comprising effective ingredients and pharmaceutically acceptable auxiliaries; the effective ingredients include, by weight, 15-35 g of dandelion herb, 9-23 g of Indian bread with hostwood, 9-23 g of jujube seed, 9-23 g of jobstears seed, 9-23 g of rhizome of common yam, 6-12 g of barley germinating fruit, 3-11 g of common jujube fruit, 6-17 g of fruit of flesh-fingered citron, 6-17 g of immature fruit of long pepper, 2-4 g of edible white-bellied swiftlet nest, and 3-7 g of root of ural licorice. Aiming at the physical and mental conditions of a patient who has been recently dragonized with acancer, the compound traditional Chinese medicine formulation with dandelion herb for use in cancer discovery stage can improve the anxious and fear emotion of the patient, improve sleep quality, improve the appetite for the patient and improve the physical conditions, such as dyspepsia and sudden decrease in immunity. On one hand, the progress of the patient's condition is controlled, and cancercell spreading is controlled; a calming drug is provided for the patient to allow the patient to relax the emotion and take treatment actively, the body is kept good, and immunity is enhanced; the patient positively takes necessary surgery and chemoradiotherapy.

The invention discloses a drug for treating malignant tumors, and the chemical structural formula is a formula (II). Malignant tumors are lung cancer, liver cancer, neurogliocytoma, adenocarcinoma of ovary, breast cancer or chronic myelogenous leukemia. The drug disclosed by the invention enriches a malignant tumor treatment compound library and plays a positive role on treatment of cancer.